Loading clinical trials...
Loading clinical trials...
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Conditions
Interventions
SYNERGY 48 mm
Locations
15
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
HealthEast St. Joseph's Hospital
Saint Paul, Minnesota, United States
New York Presbyterian Hospital - Columbia University Medical Center
New York, New York, United States
Rex Hospital
Raleigh, North Carolina, United States
Lindner Center for Research and Education at Christ Hospital
Cincinnati, Ohio, United States
York Hospital
York, Pennsylvania, United States
Start Date
April 12, 2018
Primary Completion Date
January 16, 2020
Completion Date
January 8, 2021
Last Updated
May 14, 2021
NCT07329699
NCT06863155
NCT06779630
NCT05461729
NCT07493603
NCT03854071
Lead Sponsor
Boston Scientific Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions